Haemonetics (NYSE:HAE) posted third-quarter results today that beat the consensus forecast on Wall Street and reaffirmed its total revenue guidance. The news sent shares in HAE up more than 9%. The Boston-based company reported profits of $29.9 million, or 58¢ per share, on sales of $259 million for the three months ended Dec. 31, 2019, for […]
Haemonetics
Haemonetics buys hemostasis analyzer IP
Haemonetics (NYSE:HAE) announced today that it purchased the technology underlying the TEG 6s hemostasis analyzer system from CoraMed Technologies. Braintree, Mass.-based Haemonetics now owns the intellectual property it previously licensed from CoraMed for use in hospitals and hospital laboratories, and may pursue site-of-care opportunities beyond hospitals. TEG 6s includes an analyzer, disposable cartridges and software designed […]
Haemonetics opens new Boston headquarters
Haemonetics (NYSE:HAE) said this week it opened its new global headquarters in Boston. The new location will help the company bring together its corporate and commercial teams with its research and development organization. “Relocating our headquarters to Boston is an important step in Haemonetics’ transformation,” president and CEO Chris Simon said. “Our new downtown location in […]
Haemonetics (HAE) launches SafeTrace Tx in North America
Haemonetics (NYSE:HAE) announced that it commercially launched the next generation of its SafeTrace TX transfusion management software in North America. SafeTrace TX is a specialized transfusion management system used in the blood bank for managing patient and blood product information and assisting in determining blood product suitability for patient transfusion. The updated software is designed to […]
Haemonetics beats Wall Street on Q1 EPS, revenue
Haemonetics (NYSE:HAE) posted first-quarter 2020 results today that beat the consensus forecast on Wall Street and boosted its fiscal 2020 EPS guidance. The Braintree, Mass.-based medical device maker reported a loss of -$8.48million, or -$0.17 per share, on sales of $238.5 million for the three months ended June 29, 2019, for a bottom-line loss of […]
Haemonetics wins expanded FDA nod for TEG 6s hemostasis analyzer
Haemonetics (NYSE:HAE) said on Monday that it won expanded FDA 510(k) clearance for its TEG 6s hemostasis analyzer system, now indicated for use in adult trauma settings. The TEG 6s system is comprised of an analyzer, disposable cartridges and software and is intended to provide a rapid and accurate identification of a patient’s hemostasis condition, the […]
Haemonetics deals S.C. plant to CSL Plasma for $10m
Haemonetics (NYSE:HAE) said today that it agreed to sell a plant in South Carolina to CSL Plasma for $10 million. The Union, S.C., facility makes the liquid saline and sodium citrate solutions used in plasma collection. CSL Plasma, the supplier for CSL Behring, will own and operate the plant, taking on “substantially all” of the roughly […]
Haemonetics shares fall on Q3 sales miss
Shares in Haemonetics (NYSE:HAE) have fallen nearly 10% today after the medical device maker posted fiscal year 2019 third quarter earnings that topped earnings per share estimates but missed sales consensus on Wall Street. The Braintree, Mass.-based company posted profits of approximately $18.3 million, or 35¢ per share, on sales of approximately $247.4 million for the […]
10 of the best performing medical device stocks of 2018
Updated Jan. 8, 2019 Medical device company stocks are not looking as rosy as they did two months ago, but the medtech industry still appears to be resisting the overall downward trend in stock markets, according to a Medical Design & Outsourcinganalysis. More than half of the roughly 100 largest medical device companies in the world […]
Haemonetics relocates HQ to downtown Boston
Haemonetics (NYSE:HAE) said yesterday it plans to relocate to downtown Boston from its previous home in Braintree, Mass. The move will position the blood-focused device developer in a 62,000 square-foot of space at 125 Summer Street, the company said, and will allow it to sell its 17-acre Braintree campus. “We’re excited to welcome Haemonetics to 125 Summer Street as we […]
Haemonetics post Street-beating FY 2019 Q2
Shares in Haemonetics (NYSE:HAE) have risen today after the medical device maker posted fiscal year 2019 second quarter earnings that topped expectations on Wall Street and lifted its guidance for the remaining 2019 fiscal year. The Braintree, Mass.-based company posted profits of $18.7 million, or 35¢ per share, on sales of approximately $241.6 million for the […]
